Why One Treatment Is Rarely Enough: The Case for Multimodal Facial Rejuvenation
Physician | Facial Aging and Structural Rejuvenation

Patients often come to see me with a treatment already in mind. They have heard about a device, a filler, a collagen stimulator or an injectable and want to know whether it is the answer. Sometimes it is a useful part of the answer. Rarely does the name of a treatment tell us what the face actually needs.
Facial aging does not occur in one tissue. Bone remodels, fat compartments change, supporting ligaments and soft tissues behave differently, muscles continue to influence expression, and skin gradually loses collagen and elasticity. These changes do not happen at the same rate in every person. That is why two patients of the same age, with what looks like the same concern, may need very different plans.[1–3]
When I say that one treatment is rarely enough, I am not saying that everyone needs several procedures. I mean that no single treatment can reasonably correct every mechanism of aging. Some patients need one carefully chosen treatment. Some benefit from a staged combination. Some are better served by surgery, observation or no treatment at all. The decision should follow the assessment.
A visible concern can have several causes
A jowl is a good example. It may reflect tissue descent, reduced skeletal support, changes in facial fat, skin laxity or lower-face heaviness. Treating the surface alone will not correct every one of those factors. Adding volume indiscriminately may make a heavy face look heavier. Tightening tissue may improve laxity but will not replace lost support. A resurfacing treatment may improve texture while leaving contour unchanged.
This is why I begin with a facial aging assessment rather than a treatment menu. I look at the face as a whole: structure, volume distribution, tissue position, muscle activity, skin quality and the relationship between the face and neck. I also ask what bothers the patient, how much change they want, what recovery they can accept and whether their expectation is realistic.
Related reading How We Assess Facial Aging and Why Faces Age
Different tools treat different layers

A treatment plan becomes clearer when we define the job of each treatment. Depending on the patient, that may include:
Neuromodulators to reduce selected muscle activity and soften dynamic lines.
Hyaluronic acid or another appropriate filler to restore selected areas of volume or structural support.
Collagen biostimulators to encourage gradual tissue remodeling in suitable patients. Evidence supports clinical benefit, but products, techniques and outcomes differ, and stronger comparative data are still needed.[4]
Energy-based treatments to address selected aspects of skin quality, laxity or contour. The expected effect depends on the device, treatment depth, anatomy and patient selection.[5,6]
Surface treatments to address pigmentation, texture and fine lines.
Surgery when tissue descent or excess skin is beyond what non-surgical treatment can reasonably correct.
These are not interchangeable. Each has a defined role and a limit. A natural result depends less on how many tools are used than on whether the right tool is used for the right anatomical problem.
Sequence matters
Combination treatment should not mean doing everything at once. In many cases, a staged plan is safer, easier to assess and more conservative. It lets us see what one intervention has achieved before deciding whether another is still necessary.
The sequence depends on the diagnosis. Structural support may need attention before small refinements make sense. Significant laxity may change how much volume, if any, should be added. Skin quality can be treated alongside a structural plan, but improving the surface will not reposition deeper tissue. Healing time, treatment interactions, medical history and budget also influence timing.
Published expert guidance describes layered, individualized treatment strategies and suggests that modalities can complement one another.[7] That evidence should be interpreted properly. Much of the literature evaluates specific products or relies on expert consensus. It does not prove that a fixed combination is superior for every patient. Clinical judgment and informed consent remain essential.
More treatment is not the goal
I am cautious with the idea that more must be better. A long treatment list can create cost, recovery and risk without producing a more coherent result. It can also lead to overfilling or to repeated treatment of a feature that was never the main problem.
The aim is to identify the smallest plan that can reasonably address the patient’s priorities. Sometimes that means one procedure. Sometimes it means a sequence over months. A good plan should also define where non-surgical treatment is unlikely to be enough.
For advanced tissue descent or substantial excess skin, a facelift remains more capable than a non-surgical treatment because surgery can reposition tissue and remove skin. Devices and injectables may offer meaningful improvement in selected patients, but they should not be presented as surgical equivalents.
Related reading Skin Tightening vs Facelift and QuantumRF Patient Guide
What a staged plan can look like

There is no universal protocol, but a thoughtful plan usually follows a clear logic:
Assess the face and identify the dominant mechanisms of change.
Agree on the patient’s main priority and define a realistic endpoint.
Choose the treatment most likely to address the primary mechanism.
Allow the result and healing response to develop.
Reassess before adding refinement or maintenance.
This approach also gives the patient room to stop. If the first stage achieves enough improvement, there may be no reason to continue. A treatment plan is a guide, not an obligation.
Why natural results depend on restraint
Patients often tell me they want to look rested or more like themselves, not different. That goal requires attention to proportion and movement. Treating one feature in isolation can shift the balance of the face, even when that feature looks improved on its own.
A whole-face assessment helps me decide what not to treat. It may show that a fold is secondary to midface change, that lower-face fullness should not receive more volume, or that the likely benefit of a procedure is too small to justify its burden. Restraint is part of treatment planning.
Related reading What Is Structural Facial Rejuvenation and Facial Volume Loss vs Facial Heaviness
The right starting point
If you are considering facial rejuvenation, start by asking why your face has changed rather than which treatment is popular. A useful consultation should explain the likely causes, the options that fit those causes, the limitations and risks of each option, and what improvement is realistic.
At LIFT Medical Esthetics, I use that assessment to build an individualized plan. The plan may involve one treatment or several stages. It may also conclude that treatment should wait or that surgery would be more appropriate. Clarity comes before intervention.
Book a facial aging assessment
If you would like to understand what is contributing to changes in your face, you can start your physician-led assessment. We will review your anatomy, goals, medical history, treatment options and realistic limits before recommending a plan. Initial consultations are conducted virtually, with in-person assessment arranged when appropriate.
Medical information note
This article provides general educational information and is not a substitute for an individual medical assessment. Treatment suitability, risks, recovery, sequencing and expected results vary with anatomy, health history, treatment area, product, device and technique. Individual results vary.
About the author
Dr. Willem J. Gouws, MBChB, CCFP, FPA
Dr. Willem Gouws is a physician practising aesthetic medicine in Vancouver and Squamish, British Columbia. His clinical focus includes facial aging assessment, lower-face rejuvenation, structural facial rejuvenation, ultrasound-guided treatments and skin-tightening technologies. He is a QuantumRF trainer in Canada and is involved in developing frameworks for facial aging analysis and treatment planning.
Scientific references
Evidence note: Reference 7 is an industry-funded expert-panel publication. It supports a layered clinical framework but is lower-level evidence than a comparative randomized trial. The article therefore avoids claiming that combination treatment is universally superior.

